Richard E. Pratley, MD, previews “Effect of Oral Semaglutide With or Without Background SGLT2i in Patients with T2D: Subgroup Analysis of PIONEER 4,” which will begin at 10:00 a.m. CT Saturday, June 13.
Join us in San Diego for the 83rd Scientific Sessions! Registration is now open.
Richard E. Pratley, MD, previews “Effect of Oral Semaglutide With or Without Background SGLT2i in Patients with T2D: Subgroup Analysis of PIONEER 4,” which will begin at 10:00 a.m. CT Saturday, June 13.
